A Phase I/II Study of Oblimersen Sodium (G3139, Genasense) in Combination With Oxaliplatin, 5FU and Leucovorin (FOLFOX4) Regimen in Advanced Colorectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Oblimersen (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Sep 2005 New trial record.